The authors studied CD56-expressing T cells from patients with extraarticular rheumatoid arthritis (mean age 63.9 ± 11.5) and found that CD56 molecules appeared to be functionally competent receptors on the surface of T cells which could act both as independent stimulatory receptors or as costimulatory receptors. This evidence concerns the gene NCAM1 and rheumatoid arthritis.